![Anand Parikh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 22 M $ al 31/07/2026
Anand Parikh is the founder of Faeth Therapeutics LLC, founded in 2019, holding the titles of President, Chief Executive Officer & Director since 2026.
Mr. Parikh currently holds the position of Chairman, President & Chief Executive Officer at Faeth Therapeutics, Inc. since 2026.
Mr. Parikh completed undergraduate education at the University of Michigan and graduate education at New York University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FAETH THERAPEUTICS, INC. 3,17 % | 21/07/2026 | 817.699 ( 3,17 % ) | 22 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Director Ejecutivo | 13/06/2026 |
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Fundador | 01/04/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
